https://www.selleckchem.com/products/brusatol.html
BACKGROUND Patients with inflammatory bowel disease (IBD) vaccinated for hepatitis B have a low success rate in achieving protective antibody levels. The main factors suggested for this are IBD itself and the use of immunosuppressive drugs. OBJECTIVE To evaluate the concentration of anti-HBs antibodies and to verify factors associated with the effectiveness of hepatitis B vaccination in patients with IBD. METHODS This is a prospective, consecutive, observational, descriptive and analytical, non-randomized, qualitative study that evalua
Like
Comment
Share
